ArticleJCEM case reports2026
Stiff-person syndrome with concurrent Graves disease: a rare autoimmune overlap.
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stiff-person syndrome (SPS) is an autoimmune neurologic disorder characterized by progressive rigidity and spasms, often linked to antiglutamic acid decarboxylase 65 antibodies. While SPS has established associations with autoimmune diseases like type 1 diabetes and celiac disease, co-occurrence with hyperthyroidism, particularly Graves disease (GD), is rare. We present the case of a 34-year-old woman with paranoia, hallucinations, and altered mental status. Labs revealed thyrotoxicosis, with positive thyroid-stimulating immunoglobulin and thyrotropin receptor antibodies, confirming GD. Despite antithyroid treatment, her neuropsychiatric symptoms progressed. Though the neurologic workup was unremarkable, cerebrospinal fluid studies revealed oligoclonal bands with markedly elevated antiglutamic acid decarboxylase 65 antibodies, consistent with autoimmune encephalitis within the SPS spectrum. Therapeutic plasma exchange and rituximab resulted in rapid clinical improvement. At 6 weeks, thyroid-stimulating immunoglobulin and thyrotropin receptor antibody levels normalized, and she remained stable off antithyroid therapy, suggesting resolution of GD. This case illustrates the rare coexistence of SPS and GD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.